effect isradipin atenolol lung function patient mild essenti hypertens twenty-six hypertens patient part open parallel-group pilot studi effect nine-week treatment period calcium antagonist isradipin beta agent atenolol mean dosag isradipin group mg/day mg/day atenolol group signific reduct arteri blood pressur treatment lung volum airway resist unchang atenolol-tr group linear relationship alveolar pressur resist lung volum expir forc vital capac shift airway resist chang earli sign alter air-flow behavior small airway subject suscept beta-adrenoceptor blockad calcium antagonist isradipin chang paramet lung function group patient 